Association of tricuspid regurgitation with clinical and echocardiographic outcomes after percutaneous mitral valve repair with the MitraClip System: 30-day and 12-month follow-up from the GRASP Registry

被引:118
|
作者
Ohno, Yohei [1 ,2 ]
Attizzani, Guilherme F. [1 ,3 ,4 ]
Capodanno, Davide [1 ,5 ]
Cannata, Stefano [1 ]
Dipasqua, Fabio [1 ]
Imme, Sebastiano [1 ]
Barbanti, Marco [1 ]
Ministeri, Margherita [1 ]
Caggegi, Anna [1 ]
Pistritto, Anna M. [1 ]
Chiaranda, Marta [1 ]
Ronsivalle, Giuseppe [1 ]
Giaquinta, Sandra [1 ]
Farruggio, Silvia [1 ]
Mangiafico, Sarah [1 ]
Scandura, Salvatore [1 ]
Tamburino, Corrado [1 ,5 ]
Capranzano, Piera [1 ,5 ]
Grasso, Carmelo [1 ]
机构
[1] Univ Catania, Ferrarotto Hosp, Dept Cardiol, I-95124 Catania, Italy
[2] Tokai Univ, Sch Med, Dept Cardiol, Isehara, Kanagawa 25911, Japan
[3] Univ Hosp Cleveland, Case Med Ctr, Harrington Heart & Vasc Inst, Cleveland, OH 44106 USA
[4] Pitangueiras Hosp, Dept Intervent Cardiol, Jundiai, Brazil
[5] Excellence Newest Adv ETNA Fdn, Catania, Italy
关键词
Mitral regurgitation; Percutaneous mitral valve repair; Tricuspid regurgitation; MitraClip; NATIVE VALVULAR REGURGITATION; EUROPEAN ASSOCIATION; SECONDARY; IMPACT; RECOMMENDATIONS; SEVERITY; THERAPY;
D O I
10.1093/ehjci/jeu114
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim The aim of this study was to evaluate the association of baseline tricuspid regurgitation (TR) on the outcomes after percutaneous mitral valve repair (PMVR) with the MitraClip system. Methods and results Data from 146 consecutive patients with functional mitral regurgitation (MR) were obtained. Two different groups, dichotomized according to the degree of pre-procedural TR (moderate/severe, n = 47 and none/mild, n = 99), had their clinical and echocardiographic outcomes through 12-month compared. At 30-day, the primary safety endpoint was significantly higher inmoderate/severe TR compared with none/mild TR(10.6 vs. 2.0%, P = 0.035). Marked reduction in MR grades observed post-procedure were maintained through 12 months. Although NYHA functional class significantly improved in both groups compared with baseline, it was impaired in moderate/severeTRcompared with the none/mild TR group (NYHA > II at 30 day: 33.3 vs. 9.2%, P < 0.001; at 1 year: 38.5 vs. 12.3%, respectively, P = 0.006). Left ventricle reverse remodelling and ejection fraction improvement were revealed in both groups. The primary efficacy endpoint at 12-month determined by freedom from death, surgery for mitral valve dysfunction, or grade >= 3+MR was comparable between groups, but combined death and re-hospitalization for heart failure rates were higher in the moderate/severe TR group. Multivariable Cox regression analysis demonstrated that baseline moderate/severe TR and chronic kidney disease were independent predictors of this combined endpoint. Conclusions Although PMVR with MitraClip led to improvement in MR, TR, and NYHA functional class in patients with baseline moderate/severe TR, the primary safety endpoint at 30-day was impaired, while moderate/severe TR independently predicted death and re-hospitalization for heart failure at 12-month.
引用
收藏
页码:1246 / 1255
页数:10
相关论文
共 23 条
  • [1] Gender-Related Clinical and Echocardiographic Outcomes at 30-Day and 12-Month Follow up After MitraClip Implantation in the GRASP Registry
    Attizzani, Guilherme F.
    Ohno, Yohei
    Capodanno, Davide
    Cannata, Stefano
    Dipasqua, Fabio
    Imme, Sebastiano
    Mangiafico, Sarah
    Barbanti, Marco
    Ministeri, Margherita
    Cageggi, Anna
    Pistritto, Anna Maria
    Giaquinta, Sandra
    Farruggio, Silvia
    Chiaranda, Marta
    Ronsivalle, Giuseppe
    Scandura, Salvatore
    Tamburino, Corrado
    Capranzano, Piera
    Grasso, Carmelo
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2015, 85 (05) : 889 - 897
  • [2] Impact of tricuspid regurgitation on clinical and echocardiographic outcomes after percutaneous edge-to-edge mitral valve repair: Insight from the GRASP registry
    Ohno, Y.
    Attizzani, G. F.
    Capodanno, D.
    Imme, S.
    Barbanti, M.
    Mangiafico, S.
    Scandura, S.
    Capranzano, P.
    Grasso, C.
    Tamburino, C.
    EUROPEAN HEART JOURNAL, 2014, 35 : 695 - 695
  • [3] Extended Use of Percutaneous Edge-to-Edge Mitral Valve Repair Beyond EVEREST (Endovascular Valve Edge-to-Edge Repair) Criteria 30-Day and 12-Month Clinical and Echocardiographic Outcomes From the GRASP (Getting Reduction of Mitral Insufficiency by Percutaneous Clip Implantation) Registry
    Attizzani, Guilherme F.
    Ohno, Yohei
    Capodanno, Davide
    Cannata, Stefano
    Dipasqua, Fabio
    Imme, Sebastiano
    Mangiafico, Sarah
    Barbanti, Marco
    Ministeri, Margherita
    Cageggi, Anna
    Pistritto, Anna Maria
    Giaquinta, Sandra
    Farruggio, Silvia
    Chiaranda, Marta
    Ronsivalle, Giuseppe
    Schnell, Audrey
    Scandura, Salvatore
    Tamburino, Corrado
    Capranzano, Piera
    Grasso, Carmelo
    JACC-CARDIOVASCULAR INTERVENTIONS, 2015, 8 (01) : 74 - 82
  • [4] Percutaneous Bicaval Valve Implantation for Transcatheter Treatment of Tricuspid Regurgitation Clinical Observations and 12-Month Follow-Up
    Lauten, Alexander
    Doenst, Torsten
    Hamadanchi, Ali
    Franz, Marcus
    Figulla, Hans R.
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2014, 7 (02) : 268 - +
  • [5] Impact of chronic kidney disease on outcomes after percutaneous mitral valve repair with the MitraClip system: insights from the GRASP registry
    Ohno, Yohei
    Attizzani, Guilherme F.
    Capodanno, Davide
    Barbanti, Marco
    Cannata, Stefano
    Dipasqua, Fabio
    Imme, Sebastiano
    Ministeri, Margherita
    Caggegi, Anna
    Pistritto, Anna M.
    Chiaranda, Marta
    Ronsivalle, Giuseppe
    Giaquinta, Sandra
    Mangiafico, Sarah
    Scandura, Salvatore
    Capranzano, Piera
    Tamburino, Corrado
    Grasso, Carmelo
    EUROINTERVENTION, 2016, 11 (14) : E1649 - E1657
  • [6] IMPACT OF RESIDUAL MITRAL REGURGITATION ON CLINICAL OUTCOMES AFTER ACUTE SUCCESSFUL PERCUTANEOUS MITRAL VALVE REPAIR WITH MITRACLIP SYSTEM
    Kubo, Shunsuke
    Mizutani, Yukiko
    Kar, Saibal
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A1749 - A1749
  • [7] 30-day and one-year outcomes after percutaneous aortic valve replacement: an echocardiographic follow-up study
    Blazek, Stephan
    Stoschitzky, Gergana
    Hoedl, Ronald
    Paetzold, Albrecht
    Schmidt, Albrecht
    Watzinger, Norbert
    Pieske, Burkett
    Luha, Olev
    Maier, Robert
    WIENER KLINISCHE WOCHENSCHRIFT, 2009, 121 (15-16) : A30 - A30
  • [8] Percutaneous mitral valve repair with the MitraClip system in the elderly: One-year outcomes from the GRASP registry.
    Scandura, Salvatore
    Capranzano, Piera
    Caggegi, Anna
    Grasso, Carmelo
    Ronsivalle, Giuseppe
    Mangiafico, Sarah
    Ohno, Yohei
    Attizzani, Guilherme F.
    Cannata, Stefano
    Giaquinta, Sandra
    Farruggio, Silvia
    Ministeri, Margherita
    Dipasqua, Fabio
    Pistritto, Anna M.
    Imme, Sebastiano
    Capodanno, Davide
    Di Salvo, Maria Elena
    Tamburino, Corrado
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 224 : 440 - 446
  • [9] Long-term follow-up after percutaneous mitral valve repair using the mitraclip system
    Attinger, A.
    Frangieh, A. H.
    Yoon, J.
    Gruner, C.
    Vontobel, J.
    Corti, R.
    Luescher, T. F.
    Ruschitzka, F.
    Maisano, F.
    Gaemperli, O.
    EUROPEAN HEART JOURNAL, 2015, 36 : 1124 - 1124
  • [10] Percutaneous reduction of mitral valve regurgitation using the MitraClip system - immediate and 90-day follow-up of 3 cases
    Kuebler, Piotr
    Kustrzycka-Kratochwil, Dorota
    Telichowski, Artur
    Witkowski, Tomasz
    Banasiak, Waldemar
    Jankowska, Ewa A.
    Ponikowski, Piotr
    Reczuch, Krzysztof
    POSTEPY W KARDIOLOGII INTERWENCYJNEJ, 2013, 9 (02): : 126 - 131